drugset

drugset / Trial / NCT07441980

A Clinical Study to Explore the Safety and Efficacy of CT1390B in Relapsed/ Refractory Acute Myeloid Leukemia

NCT07441980 ↗

Phase 1 Not yet recruiting 18 enrolled Institute of Hematology & Blood Diseases Hospital, China

NaSingle-groupOpen-labelTreatment

Summary

A Clinical Study to Investigate the Safety and Efficacy of CT1390B in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Timeline

Start: 2026-03-02
Primary completion: 2026-12-31
Completion: 2028-06-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CT1390B	Unknown	—	—

Indications